Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Employees’ Outside Activities Will Receive Scrutiny By Center Directors

This article was originally published in The Pink Sheet Daily

Executive Summary

Activities had been approved at lower levels, but the interim policy – issued following questions about behavior of NIH scientists – escalates the oversight. All outside activities by FDA employees will be reviewed as part of the development of a final policy.
Advertisement

Related Content

FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
FDA Will Increase Financial Disclosure Requirements For Employees
FDA Will Increase Financial Disclosure Requirements For Employees
Schering Sees No Impact From Rx Imports; Portfolio Not Attractive To "Parallel Traders"
Schering Sees No Impact From Rx Imports; Portfolio Not Attractive To "Parallel Traders"
House Committee Faults NIH Director On Lax Conflict Of Interest Policies At The Agency
House Committee Faults NIH Director On Lax Conflict Of Interest Policies At The Agency

Topics

Advertisement
UsernamePublicRestriction

Register

PS059437

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel